Retrograde transcatheter closure of ventricular septal defects in children using the Amplatzer Duct Occluder II

Koneti, Nageswara Rao; Penumatsa, Raghava Raju; Kanchi, Vasudevan; Arramraj, Srinivas K.; Jaishankar, S; Somaraju, Bhupathiraju

doi:10.1002/ccd.22675

Cited by 33 publications

(33 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…While the small diameter of the arterial vessels in infants poses an obstacle for the selection of the retrograde approach, changes in the profile of the delivery systems allowed the use of transarterial implantation technique in older children and adolescents. Recently, with this technique the Amplatzer muscular occluder device (10, 11) and ADO II device (12) have been implanted successfully in adolescents and children with congenital VSD. There are also scant case reports in that retrograde technique was used (13–15).…”

Section: Discussionmentioning

confidence: 99%

“…However, Hijazi et al (7) and Koneti et al (12) reported that kinking resistance could also occur during the retrograde approach and keeping 0.018 inches wire within the catheter until the closure device is pushed to the tip of the delivery catheter would overcome this problem. Jameel et al (10) reported difficulty to cannulate the defect and prolonged procedure time due to repeated kinking of the delivery sheath in a patient with apically located muscular defect (fluoroscopy time was 74.3 min, and procedure time was 95 min).…”

Section: Discussionmentioning

confidence: 99%

“…Some reports have described retrograde placement of the device from arterial route in cases where venous closure cannot be performed due to technical difficulties (7–9). Recently, Amplatzer muscular occluder device (10, 11) and Amplatzer Ductal Occluder 2 (ADO II) (12) device have been implanted successfully using the retrograde technique, without creating an arteriovenous guide wire loop in adolescents and children with congenital VSD. Also there are few adult case reports whose defects was closed successfully with retrograde technique (13–15).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Directly ventricular septal defect closure without using arteriovenous wire loop: Our adult case series using transarterial retrograde approach

Pekel

Ercan

Özpelit³

et al. 2017

Anatol J Cardiol

View full text Add to dashboard Cite

Objective:The standard transcatheter ventricular septal defects (VSD) closure procedure is established with arteriovenous (AV) loop and is called as antegrade approach. The directly retrograde transarterial VSD closure without using AV loop might be better option as shortens the procedure time and decreases radiation exposure.Methods:Our series consist of twelve sequential adult cases with congenital VSDs (seven with perimembranous, four with muscular, one with postoperative residuel VSD). The mean age was 26.9 (Range 18–58), the mean height was 168.75 cm (Range 155–185cm), and the mean body mass index was 23.4 (Range 17.3–28.4). Maximum and minimum defect sizes were 10 and 5 mm and the mean defect size was 6.24 mm. The procedure was performed with left heart catheterization and advancing the delivery sheath over the stiff exchange wire then VSD occlusion from left side.Results:The defects were successfully closed with this technique in eleven patients. In sixth patient, the defect could not be cannulated by the delivery sheath, as the tip of the sheath did not reach the defect and VSD was closed with same sheath by standard transvenous approach using AV loop. We didn’t encounter any complication releated to semilunar or atrioventricular valves. Atrioventricular conduction system was not affected by the procedure in any patients. The median procedure and fluoroscopy times were 66 and 16.5 minutes respectively.Conclusion:Transarterial retrograde VSD closure without using AV loop simplifies the procedure, decreases the radiation exposure, and shortens the procedure time. The only limitation in adult patients is delivery sheath length.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Directly ventricular septal defect closure without using arteriovenous wire loop: Our adult case series using transarterial retrograde approach

Pekel

Ercan

Özpelit³

et al. 2017

Anatol J Cardiol

View full text Add to dashboard Cite

show abstract

“…Goldstein and his associates [240] utilized clamshell occluder to close the VSDs. Perioperative closure of muscular VSDs was used in complex congenital heart defects as a part of overall management of the patients [241] Subsequently, buttoned device [242,243], Amplatzer muscular VSD device [244,245], detachable steel coil [246], Gianturco coils [247], Amplatzer membranous VSD occluder [248], wireless devices (Detachable balloon & transcatheter patch) [249], CardioSEAL/ STARFlex devices [250], Nit-Occlud (Nickel-Titanium Spiral Coil) [251], Amplatzer Duct Occluder [252] and Amplatzer Duct Occluder II [253] devices were used for transcatheter occlusion of VSDs.…”

Section: Ventricular Septal Defectmentioning

confidence: 99%

Historical Aspects of Transcatheter Treatment of Heart Disease in Children

Rao¹

2012

Pediat Therapeut

View full text Add to dashboard Cite

The very first transcatheter intervention to treat congenital cardiac defects was reported by Rubio-Alvarez et al. [1] in 1953, when they performed pulmonary valvotomy using a modified ureteral catheter. A decade later Dotter, Rashkind, Porstmann and their associates described progressive dilatation of peripheral arterial stenotic lesions, balloon atrial septostomy and transcatheter occlusion of patent ductus arteriosus, respectively. The purpose of this review is to present these and other historical developments of catheter-based interventions in the treatment of heart disease in children. Historical aspects of 1. balloon angioplasty/valvuloplasty of valvar pulmonary stenosis, valvar aortic stenosis, fixed subaortic stenosis, native aortic coarctation, postsurgical aortic recoarctation, branch pulmonary artery stenosis, mitral stenosis, cyanotic heart defects with pulmonary oligemia, stenotic bioprosthetic valves, congenital tricuspid and mitral stenosis, truncal valve stenosis, subvalvar pulmonary stenosis, supravalvar pulmonary stenosis (congenital membranous or postoperative), stenosis of the aorta (Leriche syndrome, atherosclerotic and Takayasu's arteritis), baffle obstruction following Mustard or Senning procedure (both systemic and pulmonary venous obstructions), superior and inferior vena caval obstructions, pulmonary vein stenosis, pulmonary veno-occlusive disease, vertical vein stenosis in total anomalous pulmonary venous connection, pulmonary venous obstruction following repair of total anomalous pulmonary venous obstruction, specially designed pulmonary artery bands, cor triatriatum, cor triatriatum dexter, and coronary artery stenotic lesions that develop after Kawasaki disease; 2. stents to enlarge stenotic lesions of branch pulmonary arteries, systemic veins, systemic and pulmonary venous pathways after Mustard procedure, aorta, right ventricular outflow conduits, pulmonary veins and native right ventricular outflow tract or to keep the ductus arteriosus open in patients with pulmonary atresia and hypoplastic left heart syndrome and maintaining patency of stenosed aorto-pulmonary collateral vessels, surgically created but obstructed shunts or acutely thrombosed shunts as well as covered stents; 3. transcatheter occlusion of cardiac defects comprising of atrial septal defect, patent foramen ovale, patent ductus arteriosus, ventricular septal defect and aortopulmonary window and 4. catheter-based atrial septostomy such as Rashkind balloon atrial septostomy, Park's blade atrial septostomy, balloon angioplasty of the atrial septum, trans-septal puncture and atrial septal stents were presented.

show abstract

“…The advantages of ADO II are its smaller delivery sheath, soft shape, and flexible implantation approach (arterial or venous side). [3]…”

mentioning

confidence: 99%

Transcatheter Closure of Multiple Membranous Ventricular Septal Defects with Giant Aneurysms Using Double Occluders in Four Patients

Zhao

Han

Zhang

et al. 2017

Chinese Medical Journal

View full text Add to dashboard Cite

Retrograde transcatheter closure of ventricular septal defects in children using the Amplatzer Duct Occluder II

Abstract: Transcatheter retrograde device closure of selected cases of Ventricular Septal Defects using the Amplatzer Duct Occluder II is simple and appears safe in the short term and can be completed within a short fluoroscopic time.

Cited by 33 publications

References 13 publications

Directly ventricular septal defect closure without using arteriovenous wire loop: Our adult case series using transarterial retrograde approach

Directly ventricular septal defect closure without using arteriovenous wire loop: Our adult case series using transarterial retrograde approach

Historical Aspects of Transcatheter Treatment of Heart Disease in Children

Transcatheter Closure of Multiple Membranous Ventricular Septal Defects with Giant Aneurysms Using Double Occluders in Four Patients

Contact Info

Product

Resources

About